Nail Disorders: Advances in Differential Diagnosis and Treatment Strategies

Nail disorders present diagnostic challenges. This article reviews the latest updates in differential diagnosis and treatment options.

Nail disorders encompass a broad spectrum of conditions that can affect the appearance and function of nails. Accurate diagnosis is essential for effective treatment, as nail presentations can overlap significantly among various disorders. Recent advancements in diagnostic techniques and treatment options provide dermatologists with new tools to better manage these conditions. Common Nail Disorders Several common nail disorders include: Onychomycosis: A fungal infection that leads to nail thickening, discoloration, and sometimes dystrophy. Psoriasis: Characterized by pitting, ridging, and onycholysis, nail psoriasis can occur in isolation or alongside skin lesions. Alopecia Areata: This autoimmune condition can affect the nails, leading to a loss of nail integrity and associated changes. Paronychia: An infection of the skin around the nail, often presenting with redness, swelling, and pain. Trauma: Physical injury to the nail can lead to various changes, including subungual hematomas and nail bed lacerations. Differential Diagnosis Establishing a differential diagnosis for nail disorders requires a thorough clinical examination, patient history, and sometimes laboratory tests. Key factors to consider include: Clinical Appearance: The morphology of the nail and surrounding tissue often provides clues. For example, the presence of pitting suggests psoriasis, while yellowish discoloration is more indicative of onychomycosis. Patient History: A history of chronic skin conditions or recent trauma can aid in diagnosis. Additionally, systemic symptoms may indicate underlying health issues. Diagnostic Tests: Nail clippings for fungal cultures, nail biopsies, or dermoscopy can provide essential information to confirm the diagnosis. Treatment Updates Recent advancements in the treatment of nail disorders have focused on both pharmacological and non-pharmacological approaches. Notable updates include: Onychomycosis: New oral antifungals, such as efinaconazole and tavaborole, s